Home > National Drug Code (NDC) > Treatment Set TS331802

Treatment Set TS331802 - 49288-0686-3 - (Treatment Set TS331802)

Alphabetical Index


Drug Information of Treatment Set TS331802

Product NDC: 49288-0686
Proprietary Name: Treatment Set TS331802
Non Proprietary Name: Treatment Set TS331802
Active Ingredient(s): .005; 10000; .005; .005; .005; .005; .005    g/mL; [AU]/mL; g/mL; g/mL; g/mL; g/mL; g/mL & nbsp;   Treatment Set TS331802
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Treatment Set TS331802

Product NDC: 49288-0686
Labeler Name: Antigen Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 19861031

Package Information of Treatment Set TS331802

Package NDC: 49288-0686-3
Package Description: 10 mL in 1 VIAL, MULTI-DOSE (49288-0686-3)

NDC Information of Treatment Set TS331802

NDC Code 49288-0686-3
Proprietary Name Treatment Set TS331802
Package Description 10 mL in 1 VIAL, MULTI-DOSE (49288-0686-3)
Product NDC 49288-0686
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Treatment Set TS331802
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19861031
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name ALTERNARIA ALTERNATA; AMBROSIA ARTEMISIIFOLIA POLLEN; ASPERGILLUS FUMIGATUS; JUGLANS NIGRA POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS ALBA POLLEN; SALSOLA KALI POLLEN
Strength Number .005; 10000; .005; .005; .005; .005; .005
Strength Unit g/mL; [AU]/mL; g/mL; g/mL; g/mL; g/mL; g/mL
Pharmaceutical Classes Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Treatment Set TS331802


General Information